Policy statements

The mission of the British Pharmacological Society is to promote and advance pharmacology. To achieve this goal it is extremely important that we engage with policy.

Consequently, the Society produces and endorses a number of statements, ranging from standalone papers and comments, to broader petitions and letters.

Browse our library of policy statements below:


Briefing paper: Barriers to legitimate research

The British Pharmacological Society and the Academy of Medical Sciences developed this briefing to inform a debate in parliament which focuses on Schedule 1 as a barrier to legitimate research. It makes three recommendations to address this, including a specific call to action on psychedelics. It builds on engagement from our organisations (and others in the research community) with ACMD and the Home Office on these issues.


Briefing paper: Embedding Research in the NHS – Cross sector Health and Care Bill briefing

The Government has set an ambition for the UK to become the destination of choice for clinical
research; an ambition shared by the UK’s research and life sciences community. We set out an opportunity to embed research within the NHS


The Society's position on medicines and COVID-19

Our current view of the key issues relating to medicines development and use during the COVID-19 pandemic


The Society’s Principles Regarding Open Science and Open Access

In March 2019, the Society’s Council agreed the following principles for the Society’s approach to open science and open access.


British Pharmacological Society comment on 2015 Spending Review (September 2015)

Professor David Webb, President-Elect of the British Pharmacological Society, commented in response to the Government's upcoming review of departmental spending, including the science budget.